Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon(R) Platform
EMERYVILLE, Calif., July 26, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon® system for antibody discovery, as well as cell and gene therapy and cell line development research. Since...
Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon® Platform
EMERYVILLE, Calif., July 26, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon® system for antibody discovery, as well as cell and gene therapy and cell line development research. Since...
Largest-Ever Industry Report Reveals Video Meetings 3x More Effective and Companies Using Them Most Gain Advantage
Data from over 130 million quarterly HCP-field interactions across 80% of global biotech and pharma companies unveiled in Veeva Pulse Field Trends Report Industrywide data shows frequent use of key digital channels is vital for effective HCP engagement PLEASANTON, Calif., July 26, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released exclusive findings...
Clinivate Provides Notice Of Data Security Incident
PASADENA, Calif., July 26, 2022 /PRNewswire/ -- Nationwide – Clinivate, LLC ("Clinivate") recently experienced a data security incident that may have involved the protected health information of individuals within Clinivate's electronic health record system. On July 22, 2022, Clinivate sent letters to the potentially impacted individuals to notify them about this incident. On March 23, 2022, Clinivate discovered unusual...
Molecular Diagnostics Developer INEX Innovate Announces Funding for New Research with The Chinese University of Hong Kong
Singapore-based diagnostics developer INEX Innovate brings The Chinese University of Hong Kong together to further research work on LEXI®, INEX's fetal cell based non-invasive pre-natal diagnostics technology. SINGAPORE, July 26, 2022 /PRNewswire/ -- Singapore-based diagnostics developer and medical laboratory operator, INEX Innovate has contributed an undisclosed sum to leading Hong Kong university...
Medicap Welcomes Two Malaysian Sportswomen as Brand Ambassadors
PUCHONG, Malaysia, July 26, 2022 /PRNewswire/ -- Malaysian healthcare company, Medicap, recently welcomed national wushu athlete Tan Cheong Min and table tennis player Ho Ying as their brand ambassadors for 2022-2024. From left, Medicap Sdn Bhd founder/CEO Mr. Lim Chin Hau. National Table Tennis player Ms. Ho Ying. National Wushu Athlete, World Wushu Champion...
CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President
Amy DuRoss joins CSafe Global as President, Cell & Gene Therapy to drive innovation and solution development MONROE, Ohio, July 26, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today that Amy DuRoss has joined the company as President, Cell and Gene Therapies (CGT). Amy DuRoss,...
Angel Yeast Partners with PhaBuilder to Open PHA Factory
YICHANG, China, July 25, 2022 /PRNewswire/ -- Angel Yeast (SH600298), a globally listed yeast and yeast extract manufacturer, has inked an agreement with Bejing PhaBuilder Biotechnology Co., Ltd (PhaBuilder) in Yichang, Hubei province to build a large manufacturing base for polyhydroxyalkanoates (PHA) in the city. The pair will set up a joint venture...
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program
SUZHOU, China and ROCKVILLE, Md. and CHARLOTTE, N.C., July 25, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Tanner Pharma Group ("Tanner Pharma"), a global pharmaceutical services provider of specialty access solutions, have jointly launched an...
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA
HANGZHOU, China, July 25, 2022 /PRNewswire/ -- Anti-PD-1 monoclonal antibody – PuyouhengTM (HX-008, pucotenlimab injection), was conditionally approved by the National Medical Products Administration (NMPA) for marketing in China to treat patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors, specifically: Patients with advanced colorectal cancers have progressed following previous...
